Elo Life Systems
PrivateLast Round
Early Funding
Jan 28, 2026
Total Funding Raised
$45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elo Life Systems operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series A Extension round in January 2024.
Elo Life Systems is a biotechnology company that specializes in precision gene editing to create sustainable, healthier food alternatives by utilizing advanced breeding technologies, genomics, and data analytics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elo Life Systems Comparables
Compare Elo Life Systems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IngredientWerks | 86% | |
| Amai Proteins | 85% | |
| Oobli | 84% |
For institutional investors. Book with your work email.
Elo Life Systems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 28, 2026 | ||||
| Series A Extension | Jan 24, 2024 | ||||
| Series A | Feb 15, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elo Life Systems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A Extension, Series A |
| Accelr8 Technology Corporation | Series A Extension, Series A |
| Hanwha Asset Management | Series A Extension |
| Hanwha Asset Management | Series A Extension |
| Novo Holdings | Series A Extension, Series A |
| Alexandria Venture Investments | Series A Extension |
| DCVC (Data Collective) | Series A Extension, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 76% MoM, reaching 4.1K.
- Jan 28, 2026
$5.4M raised in early funding.
For institutional investors. Book with your work email.
Elo Life Systems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elo Life Systems's valuation, stock price, and market status.
Is Elo Life Systems a public or private company?
Elo Life Systems is a private company.
What is the current stock price of Elo Life Systems?
Elo Life Systems is a private company, so its shares have no public market price. Caplight tracks Elo Life Systems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elo Life Systems worth (valuation)?
Valuation information for Elo Life Systems is not publicly available.
Can I buy Elo Life Systems stock?
Elo Life Systems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elo Life Systems's last funding round?
Elo Life Systems's most recent funding round was Early Funding on January 28, 2026.
Who are the main investors in Elo Life Systems?
Key investors in Elo Life Systems include DCVC Bio, Accelr8 Technology Corporation, Novo Holdings, DCVC (Data Collective), AccelR8.
Will Elo Life Systems IPO soon?
No public IPO plans have been announced for Elo Life Systems.
How can I track Elo Life Systems secondary market activity?
Caplight tracks bids, offers, and trades in Elo Life Systems's shares on secondary markets.